These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12498653)

  • 1. Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model.
    Tesh RB; Arroyo J; Travassos Da Rosa AP; Guzman H; Xiao SY; Monath TP
    Emerg Infect Dis; 2002 Dec; 8(12):1392-7. PubMed ID: 12498653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
    Iglesias MC; Frenkiel MP; Mollier K; Souque P; Despres P; Charneau P
    J Gene Med; 2006 Mar; 8(3):265-74. PubMed ID: 16308885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys.
    Muraki Y; Fujita T; Matsuura M; Fuke I; Manabe S; Ishikawa T; Okuno Y; Morita K
    Virol J; 2015 Apr; 12():54. PubMed ID: 25889682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
    Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis.
    Watts DM; Tesh RB; Siirin M; Rosa AT; Newman PC; Clements DE; Ogata S; Coller BA; Weeks-Levy C; Lieberman MM
    Vaccine; 2007 Apr; 25(15):2913-8. PubMed ID: 17067727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.
    Bonafé N; Rininger JA; Chubet RG; Foellmer HG; Fader S; Anderson JF; Bushmich SL; Anthony K; Ledizet M; Fikrig E; Koski RA; Kaplan P
    Vaccine; 2009 Jan; 27(2):213-22. PubMed ID: 18996430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baboon model for West Nile virus infection and vaccine evaluation.
    Wolf RF; Papin JF; Hines-Boykin R; Chavez-Suarez M; White GL; Sakalian M; Dittmer DP
    Virology; 2006 Nov; 355(1):44-51. PubMed ID: 16904151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2.
    Li XF; Zhao W; Lin F; Ye Q; Wang HJ; Yang D; Li SH; Zhao H; Xu YP; Ma J; Deng YQ; Zhang Y; Qin ED; Qin CF
    J Gen Virol; 2013 Dec; 94(Pt 12):2700-2709. PubMed ID: 24092759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model.
    Seino KK; Long MT; Gibbs EP; Bowen RA; Beachboard SE; Humphrey PP; Dixon MA; Bourgeois MA
    Clin Vaccine Immunol; 2007 Nov; 14(11):1465-71. PubMed ID: 17687109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for development of a vaccine against the West Nile virus.
    Monath TP
    Ann N Y Acad Sci; 2001 Dec; 951():1-12. PubMed ID: 11797767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus.
    Shrestha B; Ng T; Chu HJ; Noll M; Diamond MS
    Vaccine; 2008 Apr; 26(16):2020-33. PubMed ID: 18339459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters.
    Widman DG; Ishikawa T; Winkelmann ER; Infante E; Bourne N; Mason PW
    Vaccine; 2009 Sep; 27(41):5550-3. PubMed ID: 19635608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles vaccine expressing the secreted form of West Nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of West Nile virus infection.
    Brandler S; Marianneau P; Loth P; Lacôte S; Combredet C; Frenkiel MP; Desprès P; Contamin H; Tangy F
    J Infect Dis; 2012 Jul; 206(2):212-9. PubMed ID: 22551814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
    McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
    J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.
    Gershoni-Yahalom O; Landes S; Kleiman-Shoval S; Ben-Nathan D; Kam M; Lachmi BE; Khinich Y; Simanov M; Samina I; Eitan A; Cohen IR; Rager-Zisman B; Porgador A
    Immunology; 2010 Aug; 130(4):527-35. PubMed ID: 20331473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus.
    Verstrepen BE; Oostermeijer H; Fagrouch Z; van Heteren M; Niphuis H; Haaksma T; Kondova I; Bogers WM; de Filette M; Sanders N; Stertman L; Magnusson S; Lőrincz O; Lisziewicz J; Barzon L; Palù G; Diamond MS; Chabierski S; Ulbert S; Verschoor EJ
    PLoS One; 2014; 9(11):e112568. PubMed ID: 25392925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
    Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
    Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A live attenuated West Nile virus strain as a potential veterinary vaccine.
    Lustig S; Olshevsky U; Ben-Nathan D; Lachmi BE; Malkinson M; Kobiler D; Halevy M
    Viral Immunol; 2000; 13(4):401-10. PubMed ID: 11192286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.